Distant Recurrence Risk of HR+ BC Steady 20 Yrs After Initial Dx

Moderators

Distant Recurrence Risk of Hormone-Receptor-Positive Breast Cancer Steady 20 Years After Initial Diagnosis
November 13, 2017
After 5 years of hormonal therapy, the risk of distant recurrence is still sizable, even 20 years after the initial diagnosis, and the risk of distant recurrence is strongly linked to cancer size and number of positive lymph nodes. Read more...